PLURI
Live / Applied — Non-final action mailed (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 01 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79420419
- Mark type
- Stylized text
- Filed
- 01 Dec 2024
Goods and services
- Class 001 — Chemicals: Biological preparations for use in industry and science; bioengineered cells for use in industry and science; bioengineered human T cells for use in industry and science; human and animal cells from placentas for use in industry and science; human and animal cells from placentas for use in the manufacture of cosmetic and aesthetic products; human and animal cells from placentas for use in biological preparations for prevention of hair loss; isolated plant cells, their extracts, and components for use in industry and science; isolated and cultivated adherent cells from placenta tissue for use industry and science; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for use in industry and science; isolated and cultivated mammal cells, their extracts and components for use in industrial manufacture of foodstuff; isolated and cultivated fish cells and/or sea food animal cells for use in industrial manufacture of foodstuff; isolated and cultivated plant cells and their extracts for use in industrial manufacture of foodstuff.
- Class 005 — Pharmaceuticals: Cells and biological preparations intended for medical and clinical use; bioengineered cells and/or bioengineered tissue for medical and clinical use; bioengineered cells for use in immunotherapies for cancer and other diseases; bioengineered human T cells for medical and clinical use; human and animal cells from placentas for medical and clinical use; dietary supplements based on human and animal cells from placentas for cosmetic and aesthetic use; dietary supplements and medical preparations based on human and animal cells from placentas for use in prevention of hair loss; isolated plant cells, their extracts and components for medical and clinical use; isolated and cultivated adherent cells from placenta tissue for medical and clinical use; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for medical and clinical use; isolated and cultivated mammal cells and their extracts for medical and clinical use and preparations containing the same; isolated and cultivated fish cells and/or sea food animal cells for medical and clinical use and preparations containing the same; isolated and cultivated plant cells, their extracts and components for medical and clinical use and preparations containing the same.
- Class 042 — Scientific and technological services: Scientific and technological services and research and relating to isolation and culturing of animal cells and plant cells and to animal and plant tissues isolation and culturing, to biological preparations intended for medical, clinical, and scientific use of cultured cells and their extracts, to bioengineered cells and/or tissues, to bioengineered cells for use in immunotherapy for cancer and other diseases, to bioengineered human T cells, to isolated and cultivated human and animal placentas cells, to isolated plant cells and their extracts, to isolated and cultivated adherent cells from placenta tissue, to isolated and cultivated adherent stromal cells derived from placentas of multiple donors, to isolated and cultivated mammal cells, their extracts and preparations containing them, to isolated and cultivated fish cells and/or sea food cells and preparations containing the same, to isolated and cultivated plant cells and their extracts and preparations containing the same, to research, development and testing services in the fields of mass production of animal and plant cells, to research, development and testing services in the fields of large scale production of various cells in bioreactors.
Owner
Prosecution history
- 12 Mar 2026 — REFUSAL PROCESSED BY IB
- 20 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 20 Feb 2026 — REFUSAL PROCESSED BY MPU
- 27 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 26 Jan 2026 — NON-FINAL ACTION WRITTEN
- 24 Jan 2026 — ASSIGNED TO EXAMINER
- 23 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Apr 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB